<< Back
TASER International Releases Preliminary Data on the Respiratory Effects of TASER(TM) Device Exposure on Human Subjects

Human Test Subjects Were Able to Breathe Within Normal Limits During a 15-Second Exposure

SCOTTSDALE, Ariz., Sept. 22 /PRNewswire-FirstCall/ -- TASER International, Inc. (Nasdaq: TASR), a market leader in advanced electronic control devices announced today that preliminary results from a respiratory study indicate that subjects were able to breathe during a 15-second exposure to the TASER X26.

The study is being conducted to assess the breathing capability of human subjects during extended exposures to a TASER device. The initial results indicate the subjects were able to breathe during the exposure to the TASER X26. The subjects were placed on an FDA approved pulmonary function measurement device and subjected to three 5-second discharges with a 1-second break between cycles. A majority of the subjects exhibited a higher breathing rate and volume during the exposure than at a resting state. This study is currently ongoing and these results are preliminary in nature.

The study is being conducted by a prominent teaching hospital in the Midwest and is partially funded by TASER International. The initial results are part of a larger study that will focus on respiratory function, to include breathing rate, volume and percent CO2 expired. The full study received Institutional Review Board (IRB) approval from the researchers' institution.

The results from this study should be extremely helpful in addressing concerns related to the effects of prolonged or multiple exposures to stun devices. Recently, several media outlets misinterpreted a June, 2005 training bulletin that TASER International issued advising agencies to "avoid prolonged, extended, uninterrupted discharges or extensive multiple discharges whenever practicable in order to minimize the potential for over-exertion of the subject or potential impairment of full ability to breathe over a protracted time period." Concerns have been raised as to whether subjects were able to breathe during TASER application. The preliminary data from this study indicates that subjects indeed were able to breathe during three consecutive TASER applications.

"Given the questions raised, and the importance of releasing this data in a timely fashion, we elected to release these preliminary results as expeditiously as possible," said Rick Smith, CEO of TASER International. "We are look forward to reviewing the full results of this study and a thoughtful and constructive debate about the overall benefits of TASER technology and its role in reducing injuries and saving lives," continued Smith.

About TASER International, Inc.

TASER International, Inc. provides advanced electronic control devices for use in the law enforcement, military, private security and personal defense markets. TASER devices use proprietary technology to safely incapacitate dangerous, combative or high-risk subjects who pose a risk to law enforcement officers, innocent citizens or themselves. TASER technology saves lives every day, and the use of TASER devices dramatically reduces injury rates for officers and suspects. For more information on TASER life-saving technology, please call TASER International at (800) 978-2737 or visit our website at www.TASER.com.

Note to Investors

This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of the 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by those sections. The forward-looking information is based upon current information and expectations regarding TASER International. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.

TASER International assumes no obligation to update the information contained in this press release. TASER International's future results may be impacted by risks associated with rapid technological change, new product introductions, new technological developments and implementations, execution issues associated with new technology, ramping manufacturing production to meet demand, litigation including lawsuits resulting from alleged product related injuries, media publicity concerning allegations of deaths occurring after use of the TASER device and the negative impact this could have on sales, product quality, implementation of manufacturing automation, potential fluctuations in quarterly operating results, adjustments to these amounts which may be reflected in our 10Q filing, competition, financial and budgetary constraints of prospects and customers, international order delays, dependence upon sole and limited source suppliers, negative reports concerning TASER device uses, governmental inquiries and investigations, medical and safety studies, fluctuations in component pricing, government regulations, variation among law enforcement agencies with their TASER product experience, TASER device tests and reports, dependence upon key employees, and our ability to retain employees. TASER International's future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-QSBs and its Annual Report on Form 10-KSB.

The statements made herein are independent statements of TASER International. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.

Visit the company's web-site at www.TASER.com for facts and video.

SOURCE TASER International, Inc.
09/22/2005
CONTACT: Steve Tuttle, Vice President of Communications of TASER
International, Inc., +1-480-444-4000
Web site: http://www.taser.com
(TASR)

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding TASER International, Inc.'s business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report or Form 10-K for the most recently ended fiscal year.